Focus Areas
We are leveraging the novel mechanism of action of ensifentrine to develop innovative treatments for lung disease.
Chronic obstructive pulmonary disease (COPD) is a progressive lung condition without a cure. It damages the airways and lungs, leading to debilitating breathlessness.
Non-Cystic Fibrosis Bronchiectasis (NCFBE) is a chronic lung disease with no FDA-approved treatment. Patients suffer from persistent cough, excess sputum production and frequent respiratory infections.
Cystic fibrosis (CF) is a potentially fatal genetic disease characterized by the build-up of thick, sticky mucus and infection that can damage many of the body’s organs.
Asthma is a common chronic inflammatory disease that makes it harder to move air in and out of the lungs.
We welcome inquires from healthcare professionals seeking to learn more.